This full-day, hands-on virtual bootcamp, presented by Medical Alley and leading innovation experts, is designed to give entrepreneurs a competitive edge in the ever-evolving innovation economy. Through masterclass sessions, breakout discussions, and networking, participants will gain actionable insights into venture capital, corporate pilots, strategic partnerships, and leveraging startup support programs. Featuring a range of global leaders from Microsoft, McKesson Ventures, Novo Nordisk, and others, this program is the perfect opportunity for entrepreneurs, intrapreneurs, and anyone interested in growing in the innovation ecosystem.
In addition to the expert programming outlined above, attendees will receive the following:
- A certificate of completion from Medical Alley.
- Inclusion in the Bootcamp’s Investor Lookbook, which will highlight all startup attendees seeking investment. The Investor Lookbook will be distributed to Medical Alley’s Venture Capital network.
- Access to a Startup Resource Book of Medical Alley partners who provide services, including discounted and pro bono services, to Medical Alley startups and Bootcamp participants.
Confirmed
Speakers
Mason Chilmonczyk, PhD
Co-Founder & CEO, Andson Biotech
Mason is co-founder and CEO of the startup Andson Biotech, which is revolutionizing mass spec workflows for biopharma and beyond. His company has successfully worked with numerous top-ten biopharma and CDMOs piloting their technology from prototype to commercial product. Mason has also led his company through many prestigious programs including Y Combinator, theBioTools Innovator, and the Merck Digital Sciences Studio.
Sally Frank
Global Lead of Microsoft For Startups, Microsoft
With more than 25 years of experience in high-tech business development, sales, and marketing, Sally is passionate about helping health and life sciences companies and startups use Microsoft technology to provide better, more-cost effective care. Sally is the author of books The StartupProtocol & The Unicorn Protocol (Due out January 2026)
Tim Jarrett
Director of Lab Operations & Resident Success, LabCentral
Tim Jarrett is Director of Lab Operations & Resident Success at LabCentral, where he oversees day-to-day lab operations, shared instrumentation, and resident support across sites. He partners with sponsors and founders to accelerate R&D, scale teams, and keep the science—and the community—running smoothly. He was formerly the Site Head at Pagliuca Harvard Life Lab.Tim is trained as a scientist with experience in biotech and medical device startups.
Arnold Lee, MD
Investor & Advisor, CHAP Health Ventures
Operations Head & Physician, VocalMD
With over 18 years of combined clinical, investment, product development, and startup operating experience, Arnold is on a mission is to help build and partner with organizations to do impactful work in healthcare. He is a technologist at heart, as well as a trained physician, seasoned operational executive, healthcare AI strategist, and investor.
Lizzie Lee
Senior Associate, McKesson Ventures
Lizzie is a successful investor, portfolio leader, and senior associate at McKesson Ventures. She is passionate about connecting the innovation of novel startups with the power of industry knowledge, market research, and experience. Lizzie plays a key role moving McKesson’s innovation agenda forward.
Orly Levitan, PhD
Vice President of Pharma Business Development, Imagene
Orly is a biotechnology and life sciences executive with over 20 years of experience at the intersection of science, strategy, and business development. Throughout her accomplished career, she has secured over $50M in Total Funding (dilutive and non-dilutive), established AI-driven partnerships integrating machine learning into R&D pipelines, led due diligence & BD strategy for AI-based drug discovery and precision medicine, and negotiated multiple licensing and JV agreements with healthcare and biopharma partners.
Sabriya Stukes, PhD
Partner, SOSV | Chief Scientific Officer, IndieBio
Sabriya invests in early stage biotech companies that are solving human and planetary health problems. Prior to that she was the founding Assistant Director of the Master's in Translational Medicine (MTM) program at The City College of New York, a brand new type of graduate degree that educates and trains scientists and engineers in the hands-on process of medical technology commercialization and healthcare innovation.
Tari Suprapto, PhD
Head of Search, Novo Nordisk
Tari leads a team of global search professionals to expand and transform Novo Nordisk's pipeline. Her team collectively ensures that Novo Nordisk’spartnering visions and ambitions are well known in the industry so that Novo Nordisk becomes the preferred partner in their areas of interest. Tari has an extensive background in both science and business development.
Wesley Wierson, PhD
Founder & CEO, LEAH Laboratories
Wesley is founder and CEO of LEAH Labs, the first company to use gene editing to build solutions for disease in companion animals. Their initial product is focused on translating the success of CAR-T cells against blood malignancies in humans to our furry family members. They have successfully leveraged many non-VC fundraising strategies including crowdfunding.
Camella Wilson, PhD
Healthcare & Lifesciences Investor, Former Northpond Ventures
Camella is a successful investor with experience at Northpond Ventures andVenture University. She is excited about the cutting-edge technologies and knowledge applications that have the potential to positively impact human health, well-being, and longevity.
Christopher Woelk, PhD
External Innovation Partner, Astellas Pharma
Christopher is an innovation leader with a strong data science background and more than 20 years of experience across large pharma, startups, academia, and hospital systems. As External Innovation Partner at Astellas Pharma, he plays a key role in bridging Astellas’ internal Oncology Research with the dynamic external scientific ecosystem by proactively identifying emerging science, novel technologies, academic research, and external innovation.
Moderator
Geof Hannigan, PhD
Principal, Medical Alley - Starts
Dr. Geof Hannigan is a Principal at Medical Alley Starts. He formerly led innovation and startup acceleration programs at Merck and other organizations. His work in biotech, pharma, computational biology, and machine learning has driven digital innovation, scientific entrepreneurship, and R&D programs that advanced drug discovery and healthcare technology.
Agenda
At a Glace
Time (Eastern) | Wednesday, November 19, 2025 |
|---|---|
9:00 AM - 9:30 AM | Login & Opening Remarks |
9:30 AM - 11:00 AM | Success Stories in Funding & Partnerships |
11:00 AM - 1:00 PM | How To Be Successful With Venture Capital |
1:00 PM - 1:30 PM | Lunch Break |
1:30 PM - 3:30 PM | Effectively Leveraging Startup Support Programs |
1:30 PM - 5:30 PM | Breaking Into Pilots & Partnerships |
5:30 PM - 6:30 PM | Closing & Virtual Networking |
Disclaimer: While we do not anticipate any changes to the outlined program, the agenda may be subject to some minor changes due to circumstances beyond our control. We reserve the right to make such adjustments as needed in response to unforeseen events.